Akinobu Ito
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Middle cerebral artery occlusion due to paradoxical embolism diagnosed by pulmonary artery thrombosis in the absence of deep vein thrombosis: A case report.
Journal: Radiology case reports
Published: April 23, 2026
Escherichia coli strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance study.
Journal: JAC-antimicrobial resistance
Published: April 30, 2020
Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Journal: The Journal of antimicrobial chemotherapy
Published: November 17, 2018
Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Journal: The Journal of antimicrobial chemotherapy
Published: April 17, 2018
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria.
Journal: Antimicrobial agents and chemotherapy
Published: July 19, 2017
Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.
Journal: Diagnostic microbiology and infectious disease
Published: January 09, 2017
Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: July 03, 2016
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases.
Journal: Antimicrobial agents and chemotherapy
Published: December 25, 2015
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria.
Journal: The Journal of antimicrobial chemotherapy
Published: July 15, 2015
In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.
Journal: Antimicrobial agents and chemotherapy
Published: July 15, 2015
Potent antibacterial activities of latamoxef (moxalactam) against ESBL producing Enterobacteriaceae analyzed by Monte Carlo simulation.
Journal: The Japanese journal of antibiotics
Published: June 25, 2014
Evaluation of antibacterial activities of flomoxef against ESBL producing Enterobacteriaceae analyzed by Monte Carlo simulation.
Journal: The Japanese journal of antibiotics
Published: August 20, 2013
Last Updated: 09/26/2026